{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/84066-109#drug","name":"MEDULTIMA ADVENTURE SUNSCREEN","alternateName":"Homosalate,Octocrylene, Phenylbenzimidazole Sulfonic Acid, Ethylhexyl Salicylate, Butyl Methoxydibenzoylmethane","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"84066-109"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"M020"},{"@type":"PropertyValue","propertyID":"UNII","value":"5A68WGF6WM|4X49Y0596W|9YQ9DI1W42|G63QQF2NOX|V06SV4M95S"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"5368b2b3-fd80-9659-e063-6394a90a0ad3"}],"activeIngredient":"OCTOCRYLENE, ETHYLHEXYL SALICYLATE, PHENYLBENZIMIDAZOLE SULFONIC ACID, BUTYL METHOXYDIBENZOYLMETHANE, HOMOSALATE","administrationRoute":["TOPICAL"],"dosageForm":"CREAM","manufacturer":{"@type":"Organization","name":"Guangzhou Tata Biotechnology Co., Ltd."},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"HUMAN OTC DRUG","sameAs":["https://api.morvs.ai/drug-approval/M020","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5368b2b3-fd80-9659-e063-6394a90a0ad3","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=84066-109"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-02T01:16:22.723Z"}}